Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

3.85
Delayed Data
As of Aug 26
 +0.03 / +0.79%
Today’s Change
3.18
Today|||52-Week Range
34.40
-77.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues3.4M3.4M55.5M24.5M
 
 
 
 
 
Depreciation And Amortization313.0K94.0K139.0K223.0K
 
 
 
 
 
 
Operating ExpensesGross Income--3.3M----
 
 
General Expenses93.4M80.5M85.9M84.3M
 
 
 
 
 
Research And Development73.7M56.7M57.4M40.8M
 
 
 
 
 
Total Operating Expenses93.7M80.6M86.1M84.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-90.2M-77.2M-30.5M-60.1M
 
 
 
 
 
Interest Expense On Debt2.0K538.0K7.1M7.4M
 
 
 
 
 
Other Expenses0.000.000.00-39.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-90.1M-77.7M-37.5M-67.3M
 
 
 
 
 
Income Taxes0.000.000.00-1.4M
 
 
Net Income-90.1M-77.7M-37.5M-68.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS7.1M9.6M11.8M13.1M
 
 
 
 
 
Shares To Calculate EPS Diluted7.1M9.6M11.8M13.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$12.70-$8.00-$3.20-$5.20
 
 
 
 
 
EPS Diluted-$12.70-$8.00-$3.20-$5.20